Insider Stock Trading History of Zuerblis Kenneth J


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Zuerblis Kenneth J since year 2005. The trader's CIK number is 1007923. At the time of this reporting, Zuerblis Kenneth J is the Director of Stemline Therapeutics Inc . (stock ticker symbol STML). See this page for all insider trading activities at Stemline Therapeutics Inc .

Note that in the past ZUERBLIS KENNETH J also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Zuerblis Kenneth J since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-09-02 STML Stemline Therapeutics Inc Buy 1,000 11.14 11,143
2013-05-30 STML Stemline Therapeutics Inc Buy 900 16.38 14,742
2013-05-29 STML Stemline Therapeutics Inc Buy 2,100 15.86 33,299
2011-12-07 IMMU Immunomedics Inc Option Ex 5,000 .00 0
2011-11-18 SVNT Savient Pharmaceuticals Inc Buy 2,000 2.34 4,690
2011-09-15 SVNT Savient Pharmaceuticals Inc Buy 4,000 4.05 16,187
2011-09-14 SVNT Savient Pharmaceuticals Inc Buy 1,000 3.97 3,970
2010-12-01 IMMU Immunomedics Inc Option Ex 4,167 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Zuerblis Kenneth J (Director of Stemline Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.